Fairpoint Capital joins Vækstfonden and Finance Zealand investing millions in Neurons’ pioneering online consumer prediction technology.
Neurons Inc has secured over €6M of seed investment, in one of the largest global seed round deals ever seen. Fairpoint Capital has joined Vækstfonden and Finance Zealand, to invest in Neurons’ ground-breaking online consumer prediction tools.
The investment will be used to attract new talent to secure Neurons’ position as the undisputed global market leader in software prediction services. It will fund the development of unique, state of the art products, the scaling up of the company to 200 employees, and will bring a sizeable increase in annual recurring revenue by 2025.
Since 2013, Neurons has provided Fortune-500 companies such as Google, Coca Cola, Mercedes, Capital One, and Ikea with the technology to predict customer behaviors such as attention, focus, cognitive responses, and engagement with at least 95% accuracy in a matter of seconds. This is a unique offering. Other research companies train their AI models with publicly available data sets once. Neurons’ AI models are built and constantly updated using their leading consumer neuroscience database and because of this, reflect market trends.
In the next couple of months, Neurons will break new ground by releasing sentiment AI software to enable companies to predict not only what customers will look at, but also how they will feel.
Neurons has revolutionised the consumer insight space by harnessing the power of neuroscience and AI to provide companies with software which allows them to test customer responses at the touch of a button, instantaneously supplying more accurate consumer data than deep dive research, for a fraction of the cost. The company is committed to bringing their pioneering products to the mass market by integrating their technology into many platforms including Adobe, Chrome and Figma, as well as establishing strategic partnerships.
This sizeable investment from Fairpoint Capital, Vækstfonden, and Finance Zealand in a volatile market is testament not only to the uniqueness of the technology, but also Neurons’ potential for future global growth.
Thomas Zoega Ramsøy, Neurons Inc CEO and founder, said: “Throughout history we’ve dabbled in trying to predict human behaviour, with crystal balls and oracles, but this new combination of neuroscience and AI actually makes it possible, and with a high degree of accuracy. This seed investment allows us to scale our predictive tools and take something that is extremely complex like the brain, and AI and give it to customers in the palm of their hand. In doing so, we’re giving companies the power to create, market and sell the products and services they already know their customers want. No one else is actually doing this; predicting people’s behaviour within seconds.”
Filip Petersson, Fairpoint Capital, Investment Director, said: “We are focused on investing in amazing deep tech and making it accessible to the global market, so the decision to partner with Neurons was an easy one, even in these challenging economic times. We are thrilled to be playing a part in bringing something truly ground-breaking to businesses the world over. The ability to predict customer behaviors in a matter of seconds will revolutionise the way brands do business for many years to come.”
Jacob Bratting Pedersen, Partner at VF Direct Investment said: “We believe Neurons has the team required for scaling their unique AI technology globally. Both independently and in partnerships with leading imaging and video focused companies. Neurons make the technology available to the mass market, which in the current challenging economic environment means giving companies who might otherwise reduce spending on consumer research the opportunity to discover more about their customers, for less. We are proud to support them on their mission to scale up their business and offer something that as yet, no one else is able to.”